Two Sigma Investments, LP Crispr Therapeutics Ag Transaction History

Two Sigma Investments, LP

$41.1 Billion
Q2 2024

A detailed history of Two Sigma Investments, LP transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Two Sigma Investments, LP holds 17,059 shares of CRSP stock, worth $880,585. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,059

Previous 49,058 65.23%

Holding current value

$880,585

Previous $3.34 Million 72.45%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $1.64 Million - $2.18 Million	-31,999 Reduced 65.23%	17,059 $921,000
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $2.18 Million - $3.21 Million	-35,973 Reduced 42.31%	49,058 $3.34 Million
Q4 2023 Feb 14, 2024	SELL	$38.62 - $72.18 $5.2 Million - $9.73 Million	-134,756 Reduced 61.31%	85,031 $5.32 Million
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $9.68 Million - $12.6 Million	-213,284 Reduced 49.25%	219,787 $9.98 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $9.43 Million - $14.7 Million	217,037 Added 100.46%	433,071 $24.3 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $7.15 Million - $9.78 Million	174,303 Added 417.68%	216,034 $9.77 Million
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $2.76 Million - $4.62 Million	-70,357 Reduced 62.77%	41,731 $1.7 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $4.07 Million - $5.59 Million	66,663 Added 146.75%	112,088 $7.33 Million
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $11.8 Million - $20.2 Million	-272,949 Reduced 85.73%	45,425 $2.76 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $5.63 Million - $8.38 Million	105,790 Added 49.76%	318,374 $20 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $14.5 Million - $23.1 Million	207,310 Added 3930.79%	212,584 $16.1 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $46.9 Million - $66.7 Million	-425,751 Reduced 98.78%	5,274 $590,000
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $71.3 Million - $114 Million	-707,083 Reduced 62.13%	431,025 $69.8 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $94.9 Million - $180 Million	856,873 Added 304.68%	1,138,108 $139 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $3.4 Million - $7.4 Million	42,724 Added 17.91%	281,235 $43.1 Million
Q3 2020 Nov 16, 2020	BUY	$78.5 - $100.64 $9.49 Million - $12.2 Million	120,863 Added 102.73%	238,511 $19.9 Million
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $4.3 Million - $8.5 Million	-111,741 Reduced 48.71%	117,648 $8.65 Million
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $7.73 Million - $14.4 Million	-229,617 Reduced 50.02%	229,389 $9.73 Million
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $13.3 Million - $26.5 Million	362,978 Added 377.99%	459,006 $28 Million
Q3 2019 Nov 14, 2019	BUY	$40.99 - $52.56 $2.57 Million - $3.29 Million	62,628 Added 187.51%	96,028 $3.94 Million
Q2 2019 Aug 14, 2019	SELL	$35.45 - $48.2 $1.52 Million - $2.07 Million	-42,912 Reduced 56.23%	33,400 $1.57 Million
Q1 2019 May 15, 2019	SELL	$28.02 - $40.87 $12.1 Million - $17.7 Million	-433,260 Reduced 85.02%	76,312 $2.73 Million
Q4 2018 Feb 14, 2019	BUY	$22.73 - $42.34 $2.33 Million - $4.34 Million	102,478 Added 25.17%	509,572 $14.6 Million
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $18.1 Million - $26.8 Million	407,094 New	407,094 $18.1 Million
Q2 2018 Aug 14, 2018	SELL	$42.62 - $73.59 $4.47 Million - $7.71 Million	-104,798 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$23.52 - $58.17 $1.38 Million - $3.42 Million	58,824 Added 127.95%	104,798 $4.79 Million
Q4 2017 Feb 14, 2018	BUY	$16.95 - $23.48 $779,259 - $1.08 Million	45,974	45,974 $1.08 Million

Others Institutions Holding CRSP

# of Institutions

503

Shares Held

57M

Call Options Held

1.7M

Put Options Held

1.8M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.03B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Crispr Therapeutics Ag Transaction History